ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox

CompletedOBSERVATIONAL
Enrollment

108

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Anemia
Interventions
DRUG

Deferasirox

Trial Locations (23)

11040

Schneider Children's Hospital, New York

11201

The Brooklyn Hospital Center, Brooklyn

13210

SUNY - Upstate Medical University, Syracuse

23507

Children's Hospital of the King's Daughters, Norfolk

27858

East Carolina University, Greenville

32806

MD Anderson Cancer Center - Orlando, Orlando

33609

St. Joseph's Children's Hospital of Tampa, Tampa

36604

University of South Alabama Medical Center, Mobile

45404

Children's Medical Center, Dayton

73104

Oklahoma State University Health Sciences Center, Oklahoma City

76104

Cook's Children's Medical Center, Fort Worth

77030

Texas Children's Hospital, Houston

90027

Children's Hospital Los Angeles, Los Angeles

94304

Stanford University Medical Center, Stanford

94609

Children's Hospital Oakland, Oakland

92868-3874

Children's Hospital of Orange County, Orange

60614-3394

Children's Memorial Hospital, Chicago

02115

Children's Hospital Boston, Boston

07601

Hackensack University Medical Center, Hackensack

07503

St. Joseph's Children's Hospital, Paterson

44308-1062

Akron Children's Hospital, Akron

17033-0850

Penn State University / Milton S. Hershey Medical Center, Hershey

38105-2794

St. Jude Children's Research Hospital Memphis, Memphis

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY